| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Collaboration and other research and development revenues | $40.5M+25.4% | $32.3M | — | $19.7M-22.8% | $25.5M-71.8% | $90.7M+341.9% | $20.5M-35.7% | $31.9M+132.6% | $13.7M |
| Research and development | $90.0M-54.9% | $199.2M | — | $175.0M+22.8% | $142.5M-9.8% | $158.0M+63.1% | $96.9M+6.9% | $90.7M+9.0% | $83.2M |
| General and administrative | $49.9M-30.7% | $72.0M | — | $70.7M-7.2% | $76.2M+12.7% | $67.6M+4.7% | $64.6M+17.4% | $55.0M+8.9% | $50.5M |
| Restructuring and impairment charges | $60.7M+396.0% | $12.2M | — | — | — | — | — | — | — |
| Total operating expenses | $200.5M-29.3% | $283.5M | — | $245.7M+12.3% | $218.7M-3.1% | $225.6M+39.7% | $161.5M+10.8% | $145.7M+9.0% | $133.7M |
| Operating loss | -$160.0M+36.3% | -$251.2M | — | -$225.9M-17.0% | -$193.1M-43.2% | -$134.8M+4.3% | -$140.9M-23.9% | -$113.7M+5.2% | -$119.9M |
| Interest expense related to sale of future revenues | -$6.2M-181.8% | -$2.2M | — | — | — | — | — | — | — |
| Interest income, net | $8.3M-48.9% | $16.3M | — | $5.5M+809.1% | $607K-76.7% | $2.6M-64.4% | $7.3M+112.3% | $3.4M+452.2% | -$978K |
| Other expense, net | -$2.2M-72866.7% | -$3K | — | $0-100.0% | $37K-99.8% | $16.3M+11967.9% | -$137K-141.8% | $328K-44.1% | $587K |
| Total other income (expense), net | -$50K-100.4% | $14.1M | — | $5.5M+756.8% | $644K-96.6% | $18.9M+162.9% | $7.2M+90.2% | $3.8M+1065.0% | -$391K |
| Net loss | -$160.1M+32.5% | -$237.1M | — | -$220.4M-14.5% | -$192.5M-66.0% | -$116.0M+13.3% | -$133.7M-21.6% | -$110.0M+8.6% | -$120.3M |
| Net loss per share, basic (in dollars per share) | -$1800.00+37.5% | -$2880.00 | — | -$3210.00-12.6% | -$2850.00-43.9% | -$1980.00+26.1% | -$2680.00 | — | — |
| Net loss per share, diluted (in dollars per share) | -$1800.00+37.5% | -$2880.00 | — | -$3210.00-12.6% | -$2850.00-43.9% | -$1980.00+26.1% | -$2680.00 | — | — |
| Weighted-average common shares outstanding, basic (in shares) | 88.75B+7.8% | 82.34B | — | 68.66B+1.5% | 67.62B+15.4% | 58.61B+17.3% | 49.98B | — | — |
| Weighted-average common shares outstanding, diluted (in shares) | 88.75B+7.8% | 82.34B | — | 68.66B+1.5% | 67.62B+15.4% | 58.61B+17.3% | 49.98B | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.